Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

W. Kuhn · SciRah

Researcher profile · Semantic Scholar

W. Kuhn

Share profile

W. Kuhn — researcher profile on SciRah

h-index: 29
Works: 95
Citations: 8,648

Most-cited papers

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
R. Krüger, W. Kuhn, Thomas Müller, D. Woitalla +6 more
1998Nature Genetics2,663 citations
Semantic Scholar
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
R. Krüger, W. Kuhn, T. Müller, D. Woitalla +6 more
1998Nature Genetics2,055 citations
Semantic Scholar
Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
D. Blum-Degen, Thomas Müller, W. Kuhn, M. Gerlach +2 more
1995732 citations
Semantic Scholar
Increased susceptibility to sporadic Parkinson's disease by a certain combined α‐synuclein/apolipoprotein E genotype
R. Krüger, A. Vieira-Saecker, W. Kuhn, D. Berg +10 more
1999Annals of Neurology315 citations
Semantic Scholar
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.
D. Blum-Degen, T. Müller, W. Kuhn, M. Gerlach +2 more
1995Neuroscience Letters310 citations
Semantic Scholar
Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease.
Thomas Müller, T. Büttner, Ali Gholipour, W. Kuhn
2003Neuroscience Letters205 citations
Semantic Scholar
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
A. Storch, W. Jost, P. Vieregge, J. Spiegel +12 more
2007Archives of Neurology201 citations Open access
Semantic Scholar
Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease
S. Nuber, E. Petrasch‐Parwez, B. Winner, J. Winkler +17 more
2008Journal of Neuroscience175 citations Open access
Semantic Scholar
Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients
P. Wintermeyer, R. Krüger, W. Kuhn, Thomas Müller +10 more
2000NeuroReport153 citations Open access
Semantic Scholar
Nigral endothelial dysfunction, homocysteine, and Parkinson's disease.
Thomas Müller, Brigitte Weme, B. Fowler, W. Kuhn
1999The Lancet143 citations
Semantic Scholar
Short communication Interleukin‐6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease
T. Müller, D. Blum-Degen, H. Przuntek, W. Kuhn
1998Acta Neurologica Scandinavica134 citations Open access
Semantic Scholar
Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration.
Thomas Müller, K. Renger, W. Kuhn
2004Archives of Neurology123 citations Open access
Semantic Scholar
Familial parkinsonism with synuclein pathology
R. Krüger, W. Kuhn, K. Leenders, R. Sprengelmeyer +10 more
2001Neurology122 citations Open access
Semantic Scholar
Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease.
Thomas Müller, D. Woitalla, B. Hauptmann, B. Fowler +1 more
2001Neuroscience Letters102 citations
Semantic Scholar
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease
R. Krüger, C. Hardt, F. Tschentscher, S. Jäckel +12 more
2000Journal of neural transmission90 citations Open access
Semantic Scholar
Towards a high resolution separation of human cerebrospinal fluid.
A. Sickmann, Wilma Dormeyer, S. Wortelkamp, D. Woitalla +2 more
2002Journal of chromatography. B, Analytical technologies in the biomedical and life sciences82 citations
Semantic Scholar
Basal ganglia alterations and brain atrophy in Huntington’s disease depicted by transcranial real time sonography
T. Postert, B. Lack, W. Kuhn, M. Jergas +6 more
1999Journal of Neurology Neurosurgery & Psychiatry72 citations Open access
Semantic Scholar
Serum levels of neuron-specific enolase and s-100 protein after single tonic-clonic seizures
T. Büttner, B. Lack, Matthias Jäger, Wolfgang Wünsche +4 more
1999Journal of Neurology68 citations
Semantic Scholar
Correlation between Tapping and Inserting of Pegs in Parkinson's Disease
Thomas Müller, Sandra Schäfer, W. Kuhn, H. Przuntek
2000Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques56 citations Open access
Semantic Scholar
Tolcapone decreases plasma levels of S-adenosyl-L-homocysteine and homocysteine in treated Parkinson’s disease patients
Thomas Müller, W. Kuhn
2006European Journal of Clinical Pharmacology53 citations
Semantic Scholar
Lewy body dementia and Parkinson’s disease with dementia
R. Dodel, I. Csoti, G. Ebersbach, G. Fuchs +6 more
2008Journal of Neurology52 citations
Semantic Scholar
Homocysteine levels after acute levodopa intake in patients with Parkinson's disease
Thomas Müller, W. Kuhn
2009Movement Disorders47 citations
Semantic Scholar
Integrity of the blood-cerebrospinal fluid barrier in early Parkinson's disease.
P. Haussermann, W. Kuhn, H. Przuntek, Thomas Müller
2001Neuroscience Letters43 citations
Semantic Scholar
Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients
V. Hoffmann, W. Kuhn, S. Schimrigk, S. Islamova +6 more
2006European Journal of Neurology39 citations
Semantic Scholar
Intravenous amantadine sulphate application improves the performance of complex but not simple motor tasks in patients with Parkinson's disease.
Thomas Müller, W. Kuhn, T. Schulte, H. Przuntek
2003Neuroscience Letters37 citations
Semantic Scholar
Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson’s disease
Thomas Müller, W. Kuhn, T. Büttner, E. Eising +3 more
1998Journal of Neurology32 citations
Semantic Scholar
Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD
J. Andrich, C. Saft, A. Arz, B. Schneider +4 more
2004Movement Disorders31 citations
Semantic Scholar
Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome.
H. Reichmann, B. Janetzky, F. Bischof, P. Seibel +3 more
1994European Neurology31 citations
Semantic Scholar
Cysteine elevation in levodopa‐treated patients with Parkinson's disease
Thomas Müller, W. Kuhn
2009Movement Disorders30 citations
Semantic Scholar
The effect of R-(-)-deprenyl in de novo Parkinson patients on combination therapy with levodopa and decarboxylase inhibitor.
H. Przuntek, W. Kuhn
1987Journal of neural transmission. Supplementum28 citations
Semantic Scholar
Angiotensin I converting enzyme in cerebrospinal fluid of patients with neurological diseases
H. Schweisfurth, S. Schiöberg-Schiegnitz, W. Kuhn, B. Parusel
1987Klinische Wochenschrift28 citations
Semantic Scholar
No increased chromosomal damage in l-DOPA-treated patients with Parkinson’s disease: a pilot study
Rajaraman Gnana Oli, Gholamreza Fazeli, W. Kuhn, S. Walitza +2 more
2010Journal of neural transmission27 citations
Semantic Scholar
The Neuroimmune Hypothesis in Parkinson's Disease
W. Kuhn, Thomas Müller, Nastos Ilias, Ρoehlau Dieter
1997Reviews in the Neurosciences26 citations
Semantic Scholar
Evaluating ADS5102 (amantadine) for the treatment of Parkinson’s disease patients with dyskinesia
Thomas Müller, W. Kuhn, Jan-Dominique Möhr
2019Expert Opinion on Pharmacotherapy23 citations
Semantic Scholar
Plasma levels of R- and S-salsolinol are not increased in "de-novo" Parkinsonian patients
T. Müller, S. S. Baum, P. Haussermann, D. Woitalla +3 more
1998Journal of neural transmission23 citations
Semantic Scholar
Genetic analysis of the alpha2-macroglobulin gene in early- and late-onset Parkinson's disease.
R. Krüger, Ana M. V. Menezes-Saecker, L. Schöls, W. Kuhn +7 more
2000NeuroReport19 citations Open access
Semantic Scholar
R- and S-salsolinol are not increased in cerebrospinal fluid of Parkinsonian patients.
Thomas Müller, Siedy Sällström Baum, P. Haussermann, H. Przuntek +2 more
1999Journal of Neurological Sciences19 citations
Semantic Scholar
Colour vision abnormalities and movement time in Parkinson's disease
Thomas Müller, W. Kuhn, T. Büttner, H. Przuntek
1999European Journal of Neurology19 citations
Semantic Scholar
Evaluation of the γ-synuclein gene in German Parkinson's disease patients
R. Krüger, L. Schöls, Thomas Müller, W. Kuhn +4 more
200118 citations
Semantic Scholar
Tolcapone and neurotoxicity in Parkinson's disease.
W. Kuhn, D. Woitalla, M. Gerlach, H. Russ +1 more
1998The Lancet16 citations
Semantic Scholar
Endogenous benzodiazepine ligands in human cerebrospinal fluid.
J. Deckert, W. Kuhn, H. Przuntek
1984Peptides16 citations
Semantic Scholar
Aminoadamantanes: from treatment of Parkinson’s and Alzheimer’s disease to symptom amelioration of long COVID-19 syndrome?
Thomas Müller, P. Riederer, W. Kuhn
2023Expert Review of Clinical Pharmacology15 citations
Semantic Scholar
Levodopa Intake Increases Plasma Levels of S-Adenosylmethionine in Treated Patients With Parkinson Disease
Thomas Müller, B. Fowler, W. Kuhn
2005Clinical neuropharmacology15 citations
Semantic Scholar
No increase of synthesis of (R)salsolinol in Parkinson's disease
Thomas Müller, H. Przuntek, W. Kuhn, S. S. Baum +1 more
1999Movement Disorders12 citations
Semantic Scholar
SPECT-Evaluation of the Monoamine Uptake Site Ligand [123I](1R)- 2-Beta-Carbomethoxy-3-Beta-(4-iodophenyl)-Tropane ([123I]Beta- CIT) in Untreated Patients with Suspicion of Parkinson Disease
E. G. Eising, Thomas T. Müller, C. Zander, W. Kuhn +3 more
1997Journal of Investigative Medicine12 citations
Semantic Scholar
The interactions of 1-alkyl-4,4-diphenylpiperidines with opiate receptors.
D. Neuser, J. Stasch, Martin Witteler, W. Kuhn +3 more
1983European Journal of Pharmacology12 citations
Semantic Scholar
[3H] Diazepam Displacing Activity in Human Cerebrospinal Fluid
W. Kuhn, D. Neuser, H. Przuntek
1981Journal of Neurochemistry11 citations
Semantic Scholar
Evaluation of the gamma-synuclein gene in German Parkinson's disease patients.
R. Krüger, L. Schöls, T. Müller, W. Kuhn +4 more
2001Neuroscience Letters10 citations
Semantic Scholar
Basic science in Parkinson’s disease: its impact on clinical practice
J. Schulz, M. Gerlach, G. Gille, W. Kuhn +4 more
2011Journal of Neurology8 citations
Semantic Scholar
Generators of brain electrical activity in patients with Wilson’s disease
T. Dierks, W. Kuhn, S. Oberle, T. Müller +1 more
1999European Archives of Psychiatry and Clinical Neuroscience8 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Thomas Müller×29
Invite
Thomas Müller — researcher profile on SciRah
H. Przuntek×26
Invite
H. Przuntek — researcher profile on SciRah
D. Woitalla×13
Invite
D. Woitalla — researcher profile on SciRah
L. Schöls×10
Invite
L. Schöls — researcher profile on SciRah

×8

Invite

J. Epplen — researcher profile on SciRah

Invite

T. Müller — researcher profile on SciRah

Invite

O. Riess — researcher profile on SciRah

Invite

R. Krüger — researcher profile on SciRah

Invite

M. Gerlach — researcher profile on SciRah

Invite

T. Büttner — researcher profile on SciRah

Invite

P. Riederer — researcher profile on SciRah

Invite

G. Fuchs — researcher profile on SciRah